Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $542.76 ($5.2M) on 2026-10-13, disclosed to the SEC on 2026-10-14.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $542.76 | 639 | $347K | 6.7% |
| 2 | $543.48 | 2,340 | $1.3M | 24.5% |
| 3 | $544.56 | 1,492 | $812K | 15.7% |
| 4 | $545.52 | 1,507 | $822K | 15.9% |
| 5 | $546.46 | 1,452 | $793K | 15.3% |
| 6 | $547.47 | 630 |
| $345K |
| 6.7% |
| 7 | $548.49 | 698 | $383K | 7.4% |
| 8 | $549.47 | 502 | $276K | 5.3% |
| 9 | $550.59 | 160 | $88K | 1.7% |
| 10 | $551.49 | 80 | $44K | 0.9% |
| Total | $545.52 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |